The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
€21.74
购买此电子书可免费获赠一本！
格式 PDF ● ISBN 9781009336109 ● 出版者 Cambridge University Press ● 发布时间 2023 ● 下载 3 时 ● 货币 EUR ● ID 8807932 ● 复制保护 Adobe DRM
需要具备DRM功能的电子书阅读器
来自同一作者的更多电子书 / 编辑
44,364 此类电子书
